Neonatal jaundice is considered one of the most common reasons for admission to the pediatric medical ward. We report a case of a 1-month-old infant who presented with jaundice but no fever or any other signs of systemic illnesses. Laboratory test results revealed high direct hyperbilirubinemia, and urine culture showed a urinary tract infection with Enterobacter cloacae as the causative agent. He was admitted to the pediatric medical ward where he was treated with a course of antibiotics for 14 days, and cholestasis resolved completely following a course of antibiotics. We conclude that direct hyperbilirubinemia can be related to urinary tract infection in neonates. It is unusual for urinary tract infection to present clinically and biochemically as cholestatic jaundice.
ObjectiveThe aim was to establish the reliability of the SWRD score as a predictor of both renal and bladder outcomes in posterior urethral valves. This retrospective study included 67 patients with PUVs at King Abdul-Aziz University Hospital. The score was calculated from voiding cystourethrogram before and after the relief of obstruction, and estimated glomerular filtration rates (eGFRs) were calculated as well.ResultsBased on Spearman correlations, both baseline eGFRs and SWRD scores can be possible predictors of long-term renal outcomes, as a significant positive correlation between the baseline eGFRs and the last eGFRs was found (p = 0.005). A significant negative correlation was also found between the SWRD score calculated before the intervention and the last eGFRs (p = 0.02). Additionally, the baseline SWRD scores can be possible predictors of short-term bladder outcomes, as the correlation analysis showed a positive relationship between the baseline SWRD scores and the SWRD scores calculated within 2 months after the intervention (p < 0.0001). A significant decrease in SWRD scores and eGFRs was found from before to after the intervention, regardless of the type of intervention. In conclusion, the SWRD scoring system proved to be a potentially promising tool in the anticipation of the clinical outcomes of PUVs.
Background: Since conduction abnormalities represent a major cause of sudden death and cardiovascular complications, with a high incidence of increased length of hospital stay, risk of disabilities and healthcare costs, the aim was to discern the influence of conduction abnormalities at the time of admission on the clinical outcomes of patients admitted at the Coronary Care Unit in King Abdulaziz University Hospital. Method: The study adopted a retrospective-record review, episode-based design for a period of 2 years. All patients with sustained conduction abnormalities at the time of admission that had either self-terminated or required intervention were recruited. Statistical analysis was conducted by SPSS. Results: A total of 1763 admissions occurred during the study period, conduction abnormalities represented 11.5% of all these cases. The most common types were left bundle branch block and atrial fibrillation. Types that were significantly associated with the length of stay were atrial fibrillation (p = 0.045), ventricular tachycardia (p = 0.020), and ventricular fibrillation (p = 0.007) and complete heart block (p = 0.004). Right bundle branch block was the only conduction abnormality that was significantly associated with higher mortality (p = 0.011). Conclusion: Patients with right bundle branch block need close monitoring and optimal care to reduce risks of increased hospital stay and death. Further, it is imperative that attention should be directed in general to all patients admitted to the Coronary Care Unit with any kind of conduction abnormality in order to attempt to reduce their stay.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.